August
Xeomin receives FDA approval
The FDA has approved Merz Pharmaceuticals' botulinum toxin type A for the treatment of adults with cervical dystonia and blepharospasm
02 Aug 2010
CMPT announces CEO and loan investment
CMP Therapeutics has announced that Dr Neill Moray Mackenzie will become CEO and that the company will receive a €1.5m convertible loan investment
02 Aug 2010
DPT distribution model limited in uptake
Barr for Poland, recent moves by UK pharmacompanies to distribute products direct to the pharmacy have not been copied in other European markets, finds a new report
02 Aug 2010
New chief exec for Medical Research Council
Secretary of State for Business, Innovation and Skills Vince Cable has announced the appointment of Sir John Savill as chief executive of the MRC
02 Aug 2010
FDA lifts hold on stem-cell trial
The US Food and Drug Administration has lifted its hold on Geron's phase I study of GRNOPC1 – the first-ever human embryonic stem cell-based therapy
03 Aug 2010
New flu shots approved
The US Food and Drug Administration has approved vaccines for the 2010-2011 flu season covering three strains of flu, including the H1N1 virus
03 Aug 2010
Doctors.net.uk strengthens its pharma team
Doctors.net.uk has made two new appointments to its pharma team in response to strong organic and new business growth
03 Aug 2010
Quintiles announces new European HQ
Quintiles has announced that it is re-locating its European headquarters to Reading
03 Aug 2010
P&G's Pharmacy Care Initiative enters third year
As Procter & Gamble continues its PharmacyCare Initiative, it will reinforce its commitment to pharmacy as a core business area by showcasing three key brands nationwide
03 Aug 2010
Astellas sees profits fall
Japan-based Astellas Pharma announced a net profit fall of 10.3 per cent for the second quarter of 2010 with forecasts for the full fiscal year also down
03 Aug 2010